Stock Quote
Stock Chart
Minimum 15 minutes delayed. Source: LSEG
Week of December 16, 2024
| Date Requested | Closing Price | Volume | Split Adjustment Factor | Open Price | Day High | Day Low |
|---|---|---|---|---|---|---|
| December 16, 2024 | $20.81 | 622,655 | 1:1 | $20.46 | $21.34 | $20.00 |
| December 17, 2024 | $21.18 | 676,460 | 1:1 | $20.63 | $21.31 | $20.41 |
| December 18, 2024 | $20.24 | 1,351,114 | 1:1 | $21.18 | $21.67 | $19.60 |
| December 19, 2024 | $20.04 | 977,868 | 1:1 | $20.19 | $20.43 | $19.38 |
| December 20, 2024 | $19.83 | 2,913,842 | 1:1 | $19.90 | $20.61 | $19.66 |
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.
Minimum 15 minutes delayed. Source: LSEG
| Firm | Analyst |
|---|---|
|
Barclays
|
Peter Lawson, D. Phil. |
|
BMO Capital Markets
|
Etzer Darout, PhD |
|
H.C. Wainwright & Co
|
Robert Burns |
|
Jefferies
|
Roger Song, MD |
|
J.P. Morgan
|
Eric W. Joseph, Ph.D. |
|
Lucid Capital Markets
|
Christopher Liu |
|
Morgan Stanley & Co. LLC
|
Terence C Flynn, Ph.D. |
|
Needham & Co.
|
Gil Blum, Ph.D. |
|
Oppenheimer
|
Matthew Biegler |
|
RBC Capital Markets
|
Gregory Renza, M.D. |
|
Robert W. Baird & Co
|
Brian P. Skorney, C.F.A |
|
Stephens Inc.
|
Sudan Loganathan, Ph.D. |
|
Stifel
|
Stephen D. Willey |
|
Truist Securities
|
Srikripa Devarakonda, Ph.D. |
|
Piper Sandler
|
Joseph M. Catanzaro, Ph.D. |
|
Wells Fargo Securities, LLC
|
Derek C. Archila |
|
UBS
|
David Dai |
Nurix Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Nurix Therapeutics, Inc. 's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nurix Therapeutics, Inc. or its management. Nurix Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
'